Literature DB >> 26240152

Molecular basis for the interaction of the mammalian amino acid transporters B0AT1 and B0AT3 with their ancillary protein collectrin.

Stephen J Fairweather1, Angelika Bröer1, Nandhitha Subramanian2, Emrah Tumer1, Qi Cheng1, Dieter Schmoll3, Megan L O'Mara2, Stefan Bröer4.   

Abstract

Many solute carrier 6 (SLC6) family transporters require ancillary subunits to modify their expression and activity. The main apical membrane neutral amino acid transporters in mouse intestine and kidney, B(0)AT1 and B(0)AT3, require the ancillary protein collectrin or ACE2 for plasma membrane expression. Expression and activity of SLC6 neurotransmitter transporters are modulated by interaction with syntaxin 1A. Utilizing monocarboxylate-B(0)AT1/3 fusion constructs, we discovered that collectrin is also necessary for B(0)AT1 and B(0)AT3 catalytic function. Syntaxin 1A and syntaxin 3 inhibit the membrane expression of B(0)AT1 by competing with collectrin for access. A mutagenesis screening approach identified residues on trans-membrane domains 1α, 5, and 7 on one face of B(0)AT3 as a key region involved in interaction with collectrin. Mutant analysis established residues that were involved in collectrin-dependent functions as follows: plasma membrane expression of B(0)AT3, catalytic activation, or both. These results identify a potential binding site for collectrin and other SLC6 ancillary proteins.
© 2015 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  angiotensin-converting enzyme 2 (ACE2); broad neutral amino acid transporters; collectrin; intestinal epithelium; kidney; membrane transport; protein complex; protein-protein interaction; syntaxin 1A; syntaxin 3

Mesh:

Substances:

Year:  2015        PMID: 26240152      PMCID: PMC4591816          DOI: 10.1074/jbc.M115.648519

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  79 in total

Review 1.  Interaction of syntaxins with epithelial ion channels.

Authors:  S Saxena; M W Quick; D G Warnock
Journal:  Curr Opin Nephrol Hypertens       Date:  2000-09       Impact factor: 2.894

2.  Intracellular domains of a rat brain GABA transporter that govern transport.

Authors:  Nina Hansra; Shruti Arya; Michael W Quick
Journal:  J Neurosci       Date:  2004-04-21       Impact factor: 6.167

Review 3.  The solute carrier 6 family of transporters.

Authors:  Stefan Bröer; Ulrik Gether
Journal:  Br J Pharmacol       Date:  2012-09       Impact factor: 8.739

4.  Steady-state kinetic characterization of the mouse B(0)AT1 sodium-dependent neutral amino acid transporter.

Authors:  Simone M R Camargo; Victoria Makrides; Leila V Virkki; Ian C Forster; François Verrey
Journal:  Pflugers Arch       Date:  2005-08-26       Impact factor: 3.657

5.  Human intestine luminal ACE2 and amino acid transporter expression increased by ACE-inhibitors.

Authors:  Raphael N Vuille-dit-Bille; Simone M Camargo; Luca Emmenegger; Tom Sasse; Eva Kummer; Julia Jando; Qeumars M Hamie; Chantal F Meier; Schirin Hunziker; Zsofia Forras-Kaufmann; Sena Kuyumcu; Mark Fox; Werner Schwizer; Michael Fried; Maja Lindenmeyer; Oliver Götze; François Verrey
Journal:  Amino Acids       Date:  2014-12-23       Impact factor: 3.520

6.  Transport rates of GABA transporters: regulation by the N-terminal domain and syntaxin 1A.

Authors:  S L Deken; M L Beckman; L Boos; M W Quick
Journal:  Nat Neurosci       Date:  2000-10       Impact factor: 24.884

7.  Basigin (CD147) is the target for organomercurial inhibition of monocarboxylate transporter isoforms 1 and 4: the ancillary protein for the insensitive MCT2 is EMBIGIN (gp70).

Authors:  Marieangela C Wilson; David Meredith; Jocelyn E Manning Fox; Christine Manoharan; Andrew J Davies; Andrew P Halestrap
Journal:  J Biol Chem       Date:  2005-05-24       Impact factor: 5.157

Review 8.  Regulation of dopamine transporter function by protein-protein interactions: new discoveries and methodological challenges.

Authors:  Jacob Eriksen; Trine Nygaard Jørgensen; Ulrik Gether
Journal:  J Neurochem       Date:  2010-01-18       Impact factor: 5.372

9.  The interaction between syntaxin 1A and cystic fibrosis transmembrane conductance regulator Cl- channels is mechanistically distinct from syntaxin 1A-SNARE interactions.

Authors:  Radhika Ganeshan; Anke Di; Deborah J Nelson; Michael W Quick; Kevin L Kirk
Journal:  J Biol Chem       Date:  2002-11-22       Impact factor: 5.157

10.  The HNF-1alpha-SNARE connection.

Authors:  K Yamagata; T Nammo; Y Sato; K Saisho; H Shoda; K Fukui
Journal:  Diabetes Obes Metab       Date:  2007-11       Impact factor: 6.577

View more
  16 in total

1.  Expansion of divergent SEA domains in cell surface proteins and nucleoporin 54.

Authors:  Jimin Pei; Nick V Grishin
Journal:  Protein Sci       Date:  2017-02-13       Impact factor: 6.725

2.  Renal Collectrin Protects against Salt-Sensitive Hypertension and Is Downregulated by Angiotensin II.

Authors:  Pei-Lun Chu; Joseph C Gigliotti; Sylvia Cechova; Gabor Bodonyi-Kovacs; Fang Chan; Donna Lee Ralph; Nancy Howell; Kambiz Kalantari; Alexander L Klibanov; Robert M Carey; Alicia A McDonough; Thu H Le
Journal:  J Am Soc Nephrol       Date:  2017-01-06       Impact factor: 10.121

3.  ACE2 and pACE2: A Pair of Aces for Pulmonary Arterial Hypertension Treatment?

Authors:  Elaine M Richards; Mohan K Raizada
Journal:  Am J Respir Crit Care Med       Date:  2018-08-15       Impact factor: 21.405

4.  Identification of novel inhibitors of the amino acid transporter B0 AT1 (SLC6A19), a potential target to induce protein restriction and to treat type 2 diabetes.

Authors:  Qi Cheng; Nishank Shah; Angelika Bröer; Stephen Fairweather; Yang Jiang; Dieter Schmoll; Ben Corry; Stefan Bröer
Journal:  Br J Pharmacol       Date:  2017-02-14       Impact factor: 8.739

Review 5.  Heteromeric Solute Carriers: Function, Structure, Pathology and Pharmacology.

Authors:  Stephen J Fairweather; Nishank Shah; Stefan Brӧer
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

6.  Amino acid transporter B(0)AT1 (slc6a19) and ancillary protein: impact on function.

Authors:  Eleonora Margheritis; Francesca Guia Imperiali; Raffaella Cinquetti; Alessandra Vollero; Genciana Terova; Simona Rimoldi; Rossana Girardello; Elena Bossi
Journal:  Pflugers Arch       Date:  2016-06-02       Impact factor: 3.657

7.  Inhibiting neutral amino acid transport for the treatment of phenylketonuria.

Authors:  Adam M Belanger; Malgorzata Przybylska; Estelle Gefteas; Matthew Furgerson; Sarah Geller; Alla Kloss; Seng H Cheng; Yunxiang Zhu; Nelson S Yew
Journal:  JCI Insight       Date:  2018-07-26

8.  Spatial mRNA Expression and Response to Fasting and Refeeding of Neutral Amino Acid Transporters slc6a18 and slc6a19a in the Intestinal Epithelium of Mozambique tilapia.

Authors:  Zenith Gaye A Orozco; Satoshi Soma; Toyoji Kaneko; Soichi Watanabe
Journal:  Front Physiol       Date:  2018-03-13       Impact factor: 4.566

9.  The tyrosine transporter of Toxoplasma gondii is a member of the newly defined apicomplexan amino acid transporter (ApiAT) family.

Authors:  Kathryn E R Parker; Stephen J Fairweather; Esther Rajendran; Martin Blume; Malcolm J McConville; Stefan Bröer; Kiaran Kirk; Giel G van Dooren
Journal:  PLoS Pathog       Date:  2019-02-11       Impact factor: 6.823

Review 10.  ACE2, angiotensin 1-7 and skeletal muscle: review in the era of COVID-19.

Authors:  Koichi Yamamoto; Hikari Takeshita; Hiromi Rakugi
Journal:  Clin Sci (Lond)       Date:  2020-11-27       Impact factor: 6.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.